Return to homepagePandemic Pact

the effects of human ace-2 structural variations and mutations on sars-2-cov binding among a set population - how dna changes influence the impact of sars-2-cov and covid-19.

Grant number: 20114

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
  • Known Financial Commitments (USD)

    $2,945.04
  • Funder

    HRB Ireland
  • Principal Investigator

    Miss Eimear Carroll
  • Research Location

    Ireland
  • Lead Research Institution

    University of Galway
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Angiotensin-converting enzyme 2 (ACE-2) is a protein found in virtually all of our organs, which has come into our recent focus for being the receptor target for SARS-2-CoV, the virus which causes COVID-19 in lung tissue. The spike protein on SARS-2-CoV's shell interacts with ACE-2 in order to infiltrate our bodies. However, the makeup of ACE-2 can change from person to person, having the same function but slightly different shapes. This project is to investigate how these different shapes can have a different outcome on a person infected with coronavirus and can help discover if these different shapes or structures are why some people get high viral load and develop symptoms and some do not.

2 Publications linked via Europe PMC

Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: Recent advances in drug delivery.

Physical, mental and cognitive disabilities in relation to utilization of dental care services by nursing home residents.